执业证书号：S0010520080007 电话：13391921291 邮箱：zhengxx@hazq.com 策略分析师：刘超 [Table_StockNameRptType] 策略研究 市场点评 | 报告日期： 2025-3-11 | | --- | | [Table_RptDate] | [Table_Author] 策略分析师：郑小霞 执业证书号：S0010520090001 电话：13269985073 邮箱：liuchao@hazq.com 美股会进入熊市吗？ 主要观点 ⚫[Table_Su 市场异动 北京时间 3 月 11 日美股继续大跌，其中纳指、标普 500、道指分别收跌 4.00%、2.70%、2.08%，中概股纳斯达克金龙指数收跌 3.59%。行业层面， 标普 500 一级行业中，仅公用事业和能源上涨，信息技术（-4.34%）、可选 消费（-3.90%）、通讯服务（-3.54%）跌幅靠前。主题及个股层面，人工智 能与创新、半导体、科技巨头领跌，其中特斯拉下跌 15.43%、英伟达下跌 5.07%、苹果、脸书、谷歌均跌超 4%。CBOE 波动率攀升至 27.86 的阶段性 高点。 ⚫ 本轮 ...

- The report tracks the recent performance of the offline IPO market for the STAR Market, ChiNext, and the Main Board, assuming all stocks are hit and sold at the market average price on the first day of listing, ignoring the lock-up period restrictions [2][9] - The IPO yield for Class A accounts with a scale of 200 million is 0.66%, and for Class C accounts with a scale of 200 million is 0.56%; for Class A accounts with a scale of 1 billion, the IPO yield is 0.15%, and for Class C accounts with a scale of 1 billion, the IPO yield is 0.13% [2][9] - The average first-day increase for STAR Market stocks is 192.07%, and for ChiNext stocks, it is 385.25% [2][17] - The median number of valid quotation accounts for recent 20 new stocks is tracked, with approximately 2975 valid quotation accounts for Class A and 1876 for Class C in STAR Market; approximately 3087 valid quotation accounts for Class A and 2007 for Class C in ChiNext; approximately 3357 valid quotation accounts for Class A and 2473 for Class C in the Main Board [2][20] Model Construction Process - The report estimates the full hit yield for each stock using the average hit rate of Class A institutions. The calculation method for the full hit yield of each stock is: $$ \text{Full hit quantity} = \text{Maximum subscription limit} \times \text{Average hit rate of Class A institutions} $$ $$ \text{Full hit yield} = (\text{First board price} - \text{Initial price}) \times \text{Full hit quantity} $$ [36][38] Model Backtest Results - The full hit yield for most stocks is between 0 to 25 million yuan, with the highest being Haibosi Chuang, Junwei Electronics, and Chaoyan Shares, reaching 23.93, 20.09, and 16.86 million yuan respectively [36][38] - The report lists the offline IPO yields for different account scales, assuming all stocks are hit and sold at the market average price on the first day of listing, with a 90% capital utilization rate. For example, for a 2 billion Class A account, the IPO yield is 0.66% in 2025 [39][41][42] - The report also lists the monthly offline IPO yields for different account scales, assuming all stocks are hit and sold at the market average price on the first day of listing, with a 90% capital utilization rate. For example, for a 2 billion Class A account, the IPO yield is 4.39% in 2024 [39][41][42] Factor Construction Process - The report tracks the recent performance of the offline IPO market for the STAR Market, ChiNext, and the Main Board, assuming all stocks are hit and sold at the market average price on the first day of listing, ignoring the lock-up period restrictions [2][9] - The IPO yield for Class A accounts with a scale of 200 million is 0.66%, and for Class C accounts with a scale of 200 million is 0.56%; for Class A accounts with a scale of 1 billion, the IPO yield is 0.15%, and for Class C accounts with a scale of 1 billion, the IPO yield is 0.13% [2][9] - The average first-day increase for STAR Market stocks is 192.07%, and for ChiNext stocks, it is 385.25% [2][17] - The median number of valid quotation accounts for recent 20 new stocks is tracked, with approximately 2975 valid quotation accounts for Class A and 1876 for Class C in STAR Market; approximately 3087 valid quotation accounts for Class A and 2007 for Class C in ChiNext; approximately 3357 valid quotation accounts for Class A and 2473 for Class C in the Main Board [2][20] Factor Backtest Results - The full hit yield for most stocks is between 0 to 25 million yuan, with the highest being Haibosi Chuang, Junwei Electronics, and Chaoyan Shares, reaching 23.93, 20.09, and 16.86 million yuan respectively [36][38] - The report lists the offline IPO yields for different account scales, assuming all stocks are hit and sold at the market average price on the first day of listing, with a 90% capital utilization rate. For example, for a 2 billion Class A account, the IPO yield is 0.66% in 2025 [39][41][42] - The report also lists the monthly offline IPO yields for different account scales, assuming all stocks are hit and sold at the market average price on the first day of listing, with a 90% capital utilization rate. For example, for a 2 billion Class A account, the IPO yield is 4.39% in 2024 [39][41][42]

Investment Rating - The industry investment rating is "Overweight" [1] Core Insights - The prospects for biomanufacturing are broad, contributing to industrial upgrades. Biomanufacturing, centered on industrial biotechnology, utilizes enzymes and microbial cells in the processing of target products, including bio-based materials, chemicals, and bioenergy. Synthetic biology plays a crucial role as a platform technology in biomanufacturing. The global synthetic biology market is expected to maintain rapid growth, reaching nearly $50 billion by 2028 [3][4][22]. - Technological breakthroughs combined with policy support are driving the synthetic biology industry forward. Factors such as reduced costs of gene synthesis and sequencing, along with advancements in efficient gene editing technologies, provide a solid technical foundation for the rapid development of synthetic biology. Governments worldwide are increasingly prioritizing the development of synthetic biology, with various supportive policies being introduced [4][28]. - Synthetic biology is reshaping industrial models, offering more efficient and environmentally friendly synthesis solutions. It addresses issues associated with traditional chemical synthesis and natural extraction methods, such as high costs, limited yields, and environmental pollution. With breakthroughs in gene editing, enzyme engineering, and metabolic engineering, synthetic biology not only reduces drug production costs but also enhances capacity, enabling large-scale industrial production [4][5]. Summary by Sections Industry Overview - Biomanufacturing is defined as the processing of target products using industrial biotechnology, involving enzymes and microbial cells. Synthetic biology is a key platform technology in this field, enabling the design and construction of biological systems for various applications [13][14]. Policy Support and Technological Breakthroughs - The development of synthetic biology is supported by various policies and technological advancements. Governments are investing in funding, technology, and talent development to foster innovation and industrialization in this field [28][29]. - Major countries are establishing synthetic biology research centers and networks, with the UK and the US leading in policy initiatives to promote synthetic biology [29][30]. Synthetic Biology's Impact on Industrial Models - Synthetic biology is transforming production methods, achieving tasks that traditional biotechnologies cannot, while providing more efficient and eco-friendly synthesis options. This shift is crucial for addressing environmental challenges and enhancing production efficiency [4][5]. Investment Recommendations - Companies to watch include Chuan Ning Biological, Kingfisher Biotech, Kylin Biotech, and Huaxi Biological, which are positioned to benefit from the growth in synthetic biology [5].

Investment Rating - The industry investment rating is "Overweight" [1] Core Insights - The bio-manufacturing sector has vast potential and is poised to drive a new wave of industrial revolution, leveraging industrial biotechnology to produce bio-based materials, chemicals, and bioenergy [3][4] - The global synthetic biology market is expected to maintain rapid growth, projected to approach $50 billion by 2028, with a compound annual growth rate (CAGR) of approximately 24% from 2023 to 2028 [22][24] - Technological breakthroughs and policy support are driving the synthetic biology industry forward, with significant advancements in gene synthesis, sequencing, and editing technologies [4][37] Summary by Sections Industry Overview - Bio-manufacturing utilizes industrial biotechnology, enzymes, and microbial cells, playing a crucial role in producing bio-based materials and chemicals [13] - Synthetic biology is a design-driven science that re-engineers biological systems for useful purposes, with applications across various sectors including healthcare, agriculture, and chemicals [13][22] Policy Support and Technological Breakthroughs - Governments worldwide are increasingly prioritizing synthetic biology, with strategic plans and funding initiatives to support its development [28][29] - The reduction in costs for gene synthesis and sequencing technologies has laid a solid foundation for the rapid advancement of synthetic biology [37] Synthetic Biology Reshaping Industry Models - Synthetic biology is transforming production models, offering more efficient and environmentally friendly synthesis solutions compared to traditional methods [4][22] - The industry is expected to significantly reduce carbon emissions, with estimates suggesting a reduction of 1 to 2.5 billion tons of CO2 annually by 2030 through industrial biotechnology [4] Related Companies - Companies to watch include Chuan Ning Bio, Kingfisher Biotech, and Kailai Ying, which are positioned to benefit from advancements in synthetic biology [5] Investment Recommendations - The report suggests focusing on companies like Chuan Ning Bio, Kingfisher Biotech, and others that are leveraging synthetic biology for growth [5]

D [Table_IndNameRptType] 基础化工 行业周报 合成生物学周报：海口高新区扶持生物降解产业，巴 斯夫推出全球首个生物质平衡聚醚砜产品 | | | 报告日期： 2025-03-11 [Table_Chart] 行业指数与沪深 300 走势比较 29% -26% -15% -4% 7% 18% 3/24 6/24 9/24 12/24 3/25 基础化工 沪深300 [Table_Author] 分析师：王强峰 执业证书号：S0010522110002 电话：13621792701 邮箱：wangqf@hazq.com 分析师：刘天其 3 月 4 日，巴斯夫推出了全球首个生物质平衡聚醚砜 (PESU)产品 ——Ultrason ® E 2010 BMB，并已获得 ISCC PLUS 认证。据 悉，此产品由废弃物制成生物质原料+100%绿电生产。根据 ISCC PLUS 认证规则，生物质平衡 Ultrason ® E 2010 产品源头 使用可再生原料取代化石原料，巴斯夫表示产品所需 50%的化石 原料被 ISCC PLUS 认证的生物循环原料所取代，其中可再生原 料来自有机垃圾（即非粮生物原 ...

（九号公司689009.SH/科沃斯603486.SH/安克创新300866.SZ/萤石网络688475.SH） 2025. 03. 10 分析师：邓 欣 S0010524010001 dengxin@hazq.com 分析师：成浅之 S0010524100003 chengqianzhi@hazq.com 联系人：唐楚彦 S0010124070002 tangchuyan@hazq.com 华安证券研究所 核心要点 1、产品升级：无边界产品正处快速迭代成熟+国牌涌入做大蛋糕阶段，从25年新品可窥行业升级路径： 证券研究报告•行业专题 无边界割草机新品趋势研判 ——25年前瞻专题之消费级机器人 华安证券研究所•拓展投资价值 PART 1 ✓ 升级点：❶基础性能提升。RTK+视觉逐步成为主流技术路线，九号公司/科沃斯均有完善。九号进一步实现RTK信号增 强；科沃斯从UWB走向复合技术，激光增强RTK和视觉融合方案；❷价格双向拓宽。九号此前以$999打开市场引发"模 仿效应"，科沃斯/追觅/库犸基于现有产品向下减配补齐入门、价位段向＄1k以下小型花园设备拓展；九号则进一步向上 突破，布局＄4k以上大型花园设备； ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - Kuaishou is a leader in the AI-driven video generation field, with its AI capabilities expected to enhance advertising efficiency [1][5] - The launch of the "Keling AI" app and its various product offerings indicate a strong commitment to AI development [3][4] - The company has shown significant user growth and competitive strength in the AI model capabilities, ranking 20th in a global list of generative AI applications [4] Financial Projections - Total revenue projections for 2024-2026 are estimated at 127.3 billion, 141.4 billion, and 155.7 billion CNY respectively, reflecting a growth rate of 20%, 12%, and 11% [6][8] - Non-GAAP net profit projections for the same period are 17.6 billion, 22.7 billion, and 27.8 billion CNY, with growth rates of 279%, 72%, and 29% [6][8] - The expected EPS (Non-GAAP) for 2024-2026 is 4.10, 5.27, and 6.47 CNY respectively [8] User Growth and Product Development - As of December 2024, Keling AI has 6 million users, generating 65 million videos and 175 million images [4] - The Keling AI app has introduced various membership tiers, enhancing user engagement and monetization opportunities [3] Advertising Efficiency - AI is anticipated to improve advertising efficiency and reduce content generation costs, benefiting both small and large advertisers [5] - The increase in advertising supply is expected to enhance revenue for advertising platforms, leading to a positive industry outlook [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is a leader in the AI-driven video generation field, with its "可灵 AI" product expected to enhance advertising efficiency [1][5] - The company has launched a standalone "可灵 AI" app, expanding its AI offerings across various platforms [3] - The user base for "可灵 AI" has reached 6 million, generating 65 million videos and 175 million images, indicating strong competitive capabilities [4] - The AI technology is anticipated to lower production costs and improve advertising returns on investment (ROI), benefiting both small and large advertisers [5] Financial Projections - Total revenue projections for 2024-2026 are 127.3 billion, 141.4 billion, and 155.7 billion CNY respectively, with a growth rate of 20%, 12%, and 11% [6][8] - Non-GAAP net profit estimates for the same period are 17.6 billion, 22.7 billion, and 27.8 billion CNY, reflecting significant growth rates of 279%, 72%, and 29% [6][8] - The earnings per share (EPS) is projected to increase from 2.36 CNY in 2023 to 6.47 CNY by 2026 [8][10] Market Position - The company ranks 20th in the 2025 global list of generative AI consumer applications, surpassing competitors like Sora and Midjourney [4] - The web version of "可灵 AI" saw a 44.57% month-over-month increase in traffic, reaching 18.04 million visits in January 2025 [4]

Investment Rating - The industry investment rating is "Buy" [2] Core Insights - The report highlights the potential growth of the smart sleep market driven by AI technology, particularly focusing on smart mattresses that utilize big data and sensors to enhance sleep quality [5][26] - The smart mattress market in China is expected to grow from 1.47 billion yuan in 2017 to 3.99 billion yuan by 2026, with a CAGR of 11.73% [5][29] - Major companies in the smart mattress sector, such as Mousse and Qushui Technology, are investing significantly in R&D and production capabilities to capture market share [5][33][39] Summary by Sections Weekly Topic: AI Technology Empowering the Sleep Economy - Smart mattresses are designed to collect user data through embedded sensors, analyze sleep quality, and adjust firmness accordingly to improve sleep [5][26] - The industry chain for smart mattresses in China is mature, with upstream suppliers providing materials and components, while manufacturers operate mainly under OEM models [5][27] Weekly Market Review - From March 3 to March 7, 2025, the Shanghai Composite Index rose by 1.56%, while the light industry manufacturing sector increased by 1.34% [6][42] - The textile and apparel sector also saw a rise of 1.42% during the same period [6][42] Key Data Tracking - Real estate data indicates a significant increase in property transactions, with a 40.01% month-on-month rise in the transaction area of commercial housing in major cities [9][47] - The smart home industry in China generated revenues of 195.7 billion yuan in 2023, with a year-on-year growth of 24.49% [5][29] Industry News - Companies like Mousse have invested over 1.5 billion yuan in digital sleep industry bases since 2015, focusing on innovative smart mattress products [5][33] - Qushui Technology is leveraging its partnership with Xiaomi to enhance its smart home product offerings [5][39]

Investment Rating - The industry investment rating is "Overweight" [2] Core Insights - The report highlights the recent advancements in AI technology, particularly the launch of the first autonomous AI agent product "Manus" by Monica.im, which has achieved state-of-the-art performance in GAIA benchmark tests, surpassing similar models from OpenAI [4][6] - Tencent's app "Yuanbao" has reached the top of the App Store's free download chart in China, indicating strong market performance and user engagement [4][6] - The report emphasizes the ongoing positive trends in the AI sector, with significant developments from major companies like Baidu, Huawei, and Google, which are expected to drive further growth in the industry [5][43] Market Performance Overview - From March 3 to March 7, 2025, the Shanghai Composite Index rose by 1.56%, the ChiNext Index increased by 1.61%, and the CSI 300 Index saw a gain of 1.39%. The Hang Seng Tech Index surged by 8.43%, while the Nasdaq Index fell by 3.45% [22] - The performance of various sectors during the same period showed that the media index increased by 5.19%, the Hang Seng Internet Technology Index rose by 12.19%, and the AI index decreased by 4.74% [22] AI Developments - The report notes that Baidu is set to release its Wenxin large model 4.5 on March 16, which will feature significant enhancements in foundational model capabilities and will be open-sourced [5] - Google is developing a new Gemini model that will utilize user search history to provide personalized AI responses, indicating a shift towards more tailored AI interactions [43] - The launch of Tencent's new video generation model, which supports high-quality video production, showcases the rapid advancements in AI applications [44] Company Highlights - The report mentions that Tencent's Yuanbao app has significantly improved its ranking in the App Store, reflecting its growing popularity and user base [4][6] - The introduction of the QwQ-32B inference model by Alibaba Cloud, which boasts 32 billion parameters, is noted as a competitive advancement in the AI landscape [45] - The report identifies several companies involved in AI and computing, including Meta, Adobe, Microsoft, and Nvidia, as key players in the ongoing AI revolution [5][8]